Human filamin A is a 280 kDa protein involved in actin-filament cross-linking. It is structurally divided into an actin-binding headpiece (ABD) and a rod domain containing 24 immunoglobulin-like (Ig) repeats. A fragment of human filamin A (Ig repeats 14-16) was cloned and expressed in Escherichia coli and the purified protein was crystallized in 1.6 M ammonium sulfate, 2% PEG 1000 and 100 mM HEPES pH 7.5. The crystals diffracted to 1.95 Å and belong to space group P2 1 2 1 2 1 , with unit-cell parameters a = 50.63, b = 52.10, c = 98.46 Å , = = = 90 .
Introduction
Actin-filament architecture and dynamics contribute to the morphology and motility of cells in processes that are tightly regulated by a vast and diverse set of actin-binding proteins (ABPs). The distinct properties of ABPs have allowed classification by function as capping, severing, nucleating, sequestering and cross-linking proteins. The mechanisms of action of members of several of these classes have been clarified by the elucidation of their X-ray structures in complex with actin. However, ABPs that cross-link filamentous actin (F-actin), including filamins, -actinin and spectrin, have not been amenable to this approach owing to the implicit heterogeneity of F-actin.
Filamins were first discovered over 30 years ago as a group of F-actin cross-linking proteins that exist in Dictyostelium, chicken and mammals (Shizuta et al., 1976; Wang et al., 1975) . In humans, three different filamin genes, flna, flnb and flnc, have been identified, encoding the proteins filamins A, B and C, respectively. Filamins A and B are ubiquitously expressed (Gorlin et al., 1990; Takafuta et al., 1998) , while filamin C is predominantly expressed in cardiac and skeletal muscles (Xie et al., 1998) . The filamins are 280 kDa proteins consisting of an N-terminal actin-binding domain (ABD) headpiece followed by a C-terminal rod region (Hock et al., 1990) . The ABD comprises tandem calponin-homology domains (CH1 and CH2) that are responsible for F-actin interaction. Each 110-residue CH domain consists of six or seven -helices, four of which contain 11-18 residues. Filamin headpieces show sequence similarity to other -actininlike CH domains and are expected to adopt similar structures (Carugo et al., 1997) .
The rod region consists of repeating 100-residue immunoglobulinlike domains that are rich in -structure. In human filamins there are 24 Ig-like domains; there are 20 in Drosophila and six in Dictyostelium (Fucini et al., 1997; Popowicz et al., 2006) . Domain 24 in humans is able to homodimerize, which gives the filamin dimer a V-shape speculated to be crucial in F-actin cross-linking (Feng & Walsh, 2004; Pudas et al., 2005; Weihing, 1988) . The Ig-like domains are connected by short stretches of amino acids, with larger insertions between domains 15-16 and 23-24 that form hinges 1 and 2, respectively (Davies et al., 1978; van der Flier & Sonnenberg, 2001) . Filamins also interact with a number of transmembrane receptors that enable the actin cytoskeleton to respond to extracellular stimuli, thereby casting filamin as a scaffolding protein that bridges signalling to the cytoskeleton. Consequently, mutations in the filamin genes have been linked to various diseases, including periventricular heterotropia and the otopalatodigital (OPD) spectrum disorders (Fox et al., 1998; Robertson et al., 2003; Zenker et al., 2004) . Furthermore, aberrant filamin cleavage is associated with several conditions, including Graves' disease, myasthenia gravis, glomerulonephritis and platelet activation (Leedman et al., 1993; Peutz-Kootstra et al., 2000; Yamamoto et al., 1987) .
Crystal structures of several Ig-like domains of human filamins have been reported, including domains 17, 21, 23 and 24. These structures have revealed the dimerization interface and the interactions with Von Willebrand factor (Nakamura et al., 2006; Pudas et al., 2005) . However, these structures cover only a small proportion of the Ig-like domains and many more structures are required to provide a comprehensive description of the rod region and its interaction with binding partners. We have identified rod domains 14-16 of filamin A as a key region for structural characterization. This triplet of domains interacts with the extracellular calcium receptor (CaR), FILIP, TRAF 1 and 2 and FAP 52 and also contains the flexible hinge 1 (Awata et al., 2001; Popowicz et al., 2006; Taveau et al., 2003) . Here, we report the expression, purification, crystallization and preliminary crystallographic data analysis of filamin A repeats 14-16.
Materials and methods

Cloning, expression and purification
The DNA segment encoding human filamin A residues 1534-1875 was amplified from a human foetal kidney cDNA (Clontech). The 5 0 -primer AAAGTCGACCCCTTCAAGGTCAAGGTG and 3 0 -primer AAAGCGGCCGCTTAGAGGCCAGGCCCATA were used to amplify a 1 kbp PCR product that was inserted into the SalI and NotI sites of the pGEX-4T-3 plasmid (GE Healthcare). The DNA fragment was verified by DNA sequencing and subsequently transformed into Escherichia coli BL21 (DE3) expression cells (Invitrogen). The expressed protein has an N-terminal GST tag followed by a thrombin protease cleavage site and an extra PNSRVD linker between the thrombin cleavage site and the protein.
6 l LB medium supplemented with 100 mg ml À1 ampicillin was inoculated with 300 ml of a fresh overnight culture and grown in a glass fermenter (Bellco Glass Inc., USA) at 310 K with stirring at 150 rev min À1 until the OD 600 reached 0.8. Induction was achieved with 1 mM IPTG and expression was allowed to continue overnight at 303 K.
Cells were harvested by centrifugation in a Beckman J6-MI centrifuge at 4000 rev min À1 for 45 min at 277 K. Pellets were resuspended in GST lysis buffer (50 mM Tris pH 7.6, 150 mM NaCl and 1 mM DTT) and frozen at 193 K. Pellets frozen in lysis buffer were thawed and further lysed by sonicating on ice using a Sonicator 3000 (Misonix Incorporated).
Cell debris was pelleted by centrifugation at 18 500 rev min À1 in a Sorvall SA-300 rotor for 45 min at 277 K and the supernatant was further clarified by filtration through a 0.45 mm filter (Sartorius). The supernatant was then loaded onto an Ä KTA Xpress purification system (GE Healthcare) for passage through a GST-Trap FF 5 ml affinity column with thrombin (20 units per millilitre of beads) in GST-binding buffer (50 mM Tris pH 7.6, 150 mM NaCl and 1 mM DTT) for 10 h to remove the GST tag. The tag-free protein was then passed through a Hi-Prep 26/10 desalting column pre-equilibrated in 20 mM Tris pH 7.6 and a Resource Q anion exchanger (binding buffer, 20 mM Tris pH 7.6; elution buffer, 20 mM Tris pH 7.6, 1 M NaCl). A final Superdex 75 gel-filtration step was performed in 50 mM Tris pH 7.6, 150 mM NaCl (all columns were from GE Healthcare). Fractions containing filamin A repeats 14-16 were run on SDS-PAGE ( Fig. 1) and those judged to be pure were subsequently pooled and concentrated to 10 mg ml À1 with buffer exchange into 10 mM Tris pH 7.2, 50 mM NaCl using a 10 kDa cutoff Vivaspin membrane (Vivascience). The size on the gel corresponded to the expected 36.3 kDa tag-free protein. Prior to crystallization, the sample was checked for homogeneity by dynamic light scattering using a DynaPro MSX/TC Instrument (Protein Solutions Ltd). Crystal (dimensions 0.3 Â 0.2 Â 0.05 mm) of filamin A repeats 14-16 in 1.6 M ammonium sulfate, 2% PEG 1000 and 100 mM HEPES pH 7.5. Alhough lacking distinct edges, this lens-shaped crystal diffracted to 1.7 Å .
Crystallization and data collection
The search for crystallization conditions for concentrated filamin A repeats 14-16 was carried out via sitting-drop vapour-diffusion experiments with the aid of an Innovadyne 96+8 screenmaker (Innovadyne). 0.2 ml protein solution was mixed with 0.2 ml reservoir solution and equilibrated over 60 ml reservoir solution. Plate-like crystals were observed in several conditions from Wizard (Emerald Biosciences) and JB HTS II L (Jena Bioscience) screens at 288 K.
For cryoprotection, the crystal was soaked in a cryosolution containing mother liquor supplemented with 15% glycerol for 30 s. The crystal was then quickly mounted and cryocooled in a nitrogen cryostream at 100 K on a Rigaku/MSC FR-E Superbright X-ray source operating at 40 kV and 80 mA with a copper anode. 280 image frames were collected (120 s exposure time per frame, 0.5 oscillations) to a resolution of 1.7 Å on an R-AXIS IV ++ detector at a wavelength of 1.542 Å .
The collected data were indexed using MOSFLM (Collaborative Computational Project, Number 4, 1994) and scaling was carried out to 1.95 Å using SCALA (Collaborative Computational Project, Number 4, 1994) .
Results and discussion
The DNA segment encoding human filamin A repeats 14-16 with an N-terminal GST tag was cloned and expressed in E. coli BL21 (DE3) cells. Crystals first appeared after four weeks of incubation at 288 K and grew to final dimensions of 0.3 Â 0.2 Â 0.05 mm over a further three weeks (Fig. 2) . Data were collected from a crystal that grew in a well corresponding to 1.6 M ammonium sulfate, 2% PEG 1000 and 100 mM HEPES pH 7.5.
The space group was deduced to be P2 1 2 1 2 1 , with unit-cell parameters a = 50.63, b = 52.10, c = 98.46 Å , = = = 90 . The unit-cell volume is 259 747 Å 3 and one protein molecule is assumed per asymmetric unit (see Table 1 ).
The quality of the data indicates the possibility of solving the structure of filamin A repeats 14-16 by molecular replacement using the crystal structure of domain 24 of human filamin C (PDB code 1v05) as a start model in a multicopy search. We expect to achieve a solution from molecular replacement and refinement using the programs AMoRe and REFMAC v.5.0 (Collaborative Computational Project, Number 4, 1994) , respectively. Viewing of the molecule and manual rebuilding will be achieved with the aid of the program O (Jones et al., 1991) . 
